Apr 9 |
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
|
Mar 27 |
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
|
Mar 20 |
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 17 |
Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)
|
Mar 15 |
Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript
|
Mar 15 |
Q4 2023 Vaxart Inc Earnings Call
|
Mar 14 |
Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript
|
Mar 14 |
Vaxart Inc (VXRT) Reports Full Year 2023 Financial Results
|
Mar 14 |
Vaxart GAAP EPS of -$0.57 beats by $0.02, revenue of $7.4M beats by $2.19M
|
Mar 14 |
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
|